drugset / Trial / NCT04916093
Safety and Efficacy of Antidiabetic Drugs in Recently Diagnosed Patients With Type 2 Diabetes
RandomizedParallel-groupDouble-blindTreatment
Summary
The current study aims to investigate Sitagliptin and vildagliptin efficacy and safety compared to metformin as 1st line options for T2D patients.
Timeline
- Start
- 2019-12-20
- Primary completion
- 2020-06-10
- Completion
- 2020-12-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Metformin | Small molecule | 1000 mg | Oral |
| Subject | Sitagliptin | Small molecule | 100 mg | Oral |
| Subject | Vildagliptin | Other / unclassified | 50 mg | Oral |